Let me tell you about a hidden war being waged in Australia’s healthcare system—one that’s not fought with guns, but with spreadsheets and regulatory loopholes. Picture this: millions of Australians are paying exorbitant prices for medical devices, not because of necessity, but because of a decades-old agreement that’s quietly enriched corporations while straining private insurance premiums. This isn’t just a policy failure; it’s a moral quagmire that reveals how easily political compromises can become systemic injustices.
The Prescribed List—a 10,000-item price schedule for surgical hardware—is the linchpin of this mess. It’s a bureaucratic relic that forces private insurers to pay up to three times what public hospitals pay for the same devices. Think about that: if you’re privately insured, your insurer is effectively subsidizing the profits of multinational device manufacturers while you’re stuck with higher premiums. What makes this particularly fascinating is how it’s not a secret. The numbers are out there, but no one seems to care. Why? Because the system benefits a powerful lobby, and politicians are too afraid to rock the boat.
Stephen Duckett, a former health department head, calls it a ‘legalised transfer of wealth’ from ordinary Australians to corporate giants. That’s not hyperbole. When the government mandates a 7% price floor above what public hospitals pay, it’s not just a bureaucratic tick-box exercise—it’s a calculated decision to let profits flow freely. And here’s the kicker: even when prices drop, the total outlays remain stubbornly high. Why? Because hospitals are using more devices per procedure. It’s a classic case of ‘if you can’t beat them, join them’—except in this case, the ‘them’ are the very companies exploiting the system.
Let’s talk about the numbers. For a cardiac defibrillator, private insurers pay $36,500, while public hospitals get it for $14,500. That’s a 157% markup. Multiply that across 14 million privately insured Australians, and you’re talking about billions in unearned profits. What many people don’t realize is that this isn’t just about money—it’s about power. The Medical Technology Association of Australia, which lobbied for this system, has effectively turned the government into its own enforcer. And when Labor took over, they didn’t dismantle the agreement. They doubled down. Why? Because political will is a luxury in a system where both sides benefit from the status quo.
Here’s where it gets even darker. A recent review by the Nous Group confirmed what critics have long suspected: Australian device prices are ‘significantly higher’ than in comparable countries. Yet the industry dismisses these comparisons as apples-to-oranges. But that’s a weak excuse. If the system were truly efficient, wouldn’t it be able to compete on price? Instead, we’re told that New Zealand’s centralized procurement model isn’t ‘compatible’ with Australia’s fragmented private system. Translation: we’re too lazy to fix it.
And what about the insurers? They’re not exactly victims here. Private health funds raked in $2.1 billion in net profit last year, while management expenses hit $3.4 billion. That’s not efficiency—that’s profiteering. When device companies lower their prices, insurers pocket the difference instead of passing savings to policyholders. It’s a textbook example of how market forces fail when regulation is designed to protect interests, not consumers.
This isn’t just about healthcare. It’s a microcosm of how political systems can become trapped in self-serving cycles. Greg Hunt’s 2022 agreement was supposed to ‘secure structural savings,’ but the real savings went to corporate balance sheets. Now, with Labor in power, the same bureaucrats who warned against the deal are forced to defend it. It’s a tragic irony that the people meant to serve the public interest are the ones enabling the very system that undermines it.
If you take a step back and think about it, this entire saga raises a deeper question: who truly controls Australia’s healthcare system? Is it the politicians, the bureaucrats, the insurers, or the corporations? The answer is probably all of them—and none of them. It’s a tangled web of vested interests where no one wants to bear the cost of reform. But here’s the thing: this isn’t sustainable. As long as Australians are paying a premium for devices that cost less elsewhere, the system will continue to erode trust in both government and private enterprise. The only way forward is to tear down the Prescribed List and rebuild a system that prioritizes people over profits. Until then, we’ll keep watching as billions flow into the pockets of those who don’t need it most.
